Management of inflammatory neuropathies.
Hadden
Robert D M
RD
West London Neurosciences Centre, Charing Cross Hospital, London, UK. rob.hadden@doctors.org.uk
Hughes
Richard A C
RA
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001797:Blood Protein Electrophoresis / Q000379:methods; D003937:Diagnosis, Differential; D020275:Guillain-Barre Syndrome / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D019846:Miller Fisher Syndrome / Q000503:physiopathology / Q000628:therapy*; D009431:Neural Conduction / Q000502:physiology; D010264:Paraplegia / Q000175:diagnosis; D010265:Paraproteinemias / Q000175:diagnosis; D010951:Plasma Exchange; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D013256:Steroids
D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; D013256:Steroids